Publicacions en col·laboració amb investigadors/es de Clínica Universitaria de Navarra (17)

2024

  1. Inflammatory markers as diagnostic and precision nutrition tools for metabolic dysfunction-associated steatotic liver disease: Results from the Fatty Liver in Obesity trial

    Clinical Nutrition, Vol. 43, Núm. 7, pp. 1770-1781

2015

  1. Strict requirement for vector-induced type I interferon in efficacious antitumor responses to virally encoded IL12

    Cancer Research, Vol. 75, Núm. 3, pp. 497-507

2014

  1. Dysregulation of interferon regulatory factors impairs the expression of immunostimulatory molecules in hepatitis C virus genotype 1-infected hepatocytes

    Gut, Vol. 63, Núm. 4, pp. 665-673

2013

  1. Usage of Adenovirus Expressing Thymidine Kinase Mediated Hepatocellular Damage for Enabling Mouse Liver Repopulation with Allogenic or Xenogenic Hepatocytes

    PLoS ONE, Vol. 8, Núm. 9

2012

  1. CD8 T cell priming in the presence of IFN-α renders CTLs with improved responsiveness to homeostatic cytokines and recall antigens: important traits for adoptive T cell therapy

    Journal of Immunology, Vol. 189, Núm. 7, pp. 3299-3310

2011

  1. A signature of six genes highlights defects on cell growth and specific metabolic pathways in murine and human hepatocellular carcinoma

    Functional and Integrative Genomics, Vol. 11, Núm. 3, pp. 419-429

  2. Improved dendritic cell-based immunization against hepatitis C virus using peptide inhibitors of interleukin 10

    Hepatology, Vol. 53, Núm. 1, pp. 23-31

2010

  1. Effects of IFN-α as a signal-3 cytokine on human naïve and antigen-experienced CD8+ T cells

    European Journal of Immunology, Vol. 40, Núm. 12, pp. 3389-3402

2006

  1. Recombinant Adenoviral Vectors Turn on the Type I Interferon System without Inhibition of Transgene Expression and Viral Replication

    Molecular Therapy, Vol. 14, Núm. 1, pp. 129-138

2002

  1. The woodchuck interferon-α system: Cloning, family description, and biologic activity

    Journal of Medical Virology, Vol. 68, Núm. 3, pp. 424-432

1998

  1. Effectiveness of lamivudine in treatment of acute recurrent hepatitis B after liver transplantation

    Digestive Diseases and Sciences, Vol. 43, Núm. 6, pp. 1186-1189

1997

  1. Viremia after one month of interferon therapy predicts treatment outcome in patients with chronic hepatitis C

    Gastroenterology, Vol. 113, Núm. 5, pp. 1647-1653

1996

  1. Anticardiolipin antibodies in chronic hepatitis C: Implication of hepatitis C virus as the cause of the antiphospholipid syndrome

    Hepatology, Vol. 23, Núm. 2, pp. 199-204

1994

  1. Prediction of sustained remission of chronic hepatitis C after a 12-month course of alfa interferon

    Journal of Hepatology, Vol. 21, Núm. 1, pp. 4-11

1993

  1. Prediction of the response of chronic hepatitis C to interferon alfa: A statistical analysis of pretreatment variables

    Gut, Vol. 34, Núm. 12, pp. 1714-1717

1992

  1. Hepatitis B and C viral infections in patients with hepatocellular carcinoma

    Hepatology, Vol. 16, Núm. 3, pp. 637-641

1990

  1. Virus herpes humano tipo 6 y síndrome de astenia crónica.

    Medicina clinica, Vol. 94, Núm. 19, pp. 721-724